1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Chamberlin, S.G.
Brennan, L.
Puddicombe, S.M.
Davies, D.E.
Turner, D.L.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
IX
Eur.J.Biochem.
EJBCAI
0262
0014-2956
268
6247
10.1046/J.0014-2956.2001.02581.X
11733021
Solution Structure of the Megf/Tgfalpha44-50 Chimeric Growth Factor.
2001
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
271
30392
10.1074/JBC.271.48.30392
8940002
The Interaction of an Epidermal Growth Factor/ Transforming Growth Factor Alpha Tail Chimera with the Human Epidermal Growth Factor Receptor Reveals Unexpected Complexities
1996
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
THE PROTEIN IS A CHIMERA OF EPIDERMAL GROWTH FACTOR RESIDUES 977-1018 AND HUMAN TRANSFORMING GROWTH FACTOR ALPHA RESIDUES 83-89,THE PROTEIN IS A CHIMERA OF EPIDERMAL GROWTH FACTOR RESIDUES 977-1018 AND HUMAN TRANSFORMING GROWTH FACTOR ALPHA RESIDUES 83-89
5257.785
Pro-epidermal growth factor,Protransforming growth factor alpha
UNP residues 977-1018,UNP residues 83-89
1
man
polymer
EGF
no
no
NSYPGCPSSYDGYCLNGGVCMHIESLDSYTCNCVIGYSGDRCEHADLLA
NSYPGCPSSYDGYCLNGGVCMHIESLDSYTCNCVIGYSGDRCEHADLLA
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
House Mouse
Pichia pastoris
sample
1
42
Egf
10090
Mus musculus
4922
Komagataella pastoris
pPIC9
Plasmid
Biological sequence
Human
Pichia pastoris
sample
43
49
TGFA
9606
Homo sapiens
4922
Komagataella pastoris
pPIC9
Plasmid
Biological sequence
entity
entity_name_com
entity_src_gen
entity_src_nat
struct_ref
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Source and taxonomy
Structure summary
1
0
2002-08-08
1
1
2011-05-08
1
2
2011-07-13
1
3
2018-03-28
_entity.details
_entity.pdbx_description
_entity.pdbx_fragment
_entity.src_method
_entity_name_com.name
_struct_ref.pdbx_align_begin
_struct_ref.pdbx_seq_one_letter_code
PDBE
Y
PDBE
2001-08-08
REL
LEAST RESTRAINT VIOLATION
50
10
2D-1H-NOESY 2D-1H-TOCSY 2D-1H-COSY
3.0
pH
298
K
TORSION ANGLE DYNAMICS WITH SIMULATED ANNEALING
1
BRENNAN L, TURNER DL, MESSIAS AM, TEODORO ML, LEGALL J, SANTOS H, XAVIER AX.
refinement
INDYANA
structure solution
INDYANA
500
Varian
VXR500
ASN
1
n
1
ASN
1
A
SER
2
n
2
SER
2
A
TYR
3
n
3
TYR
3
A
PRO
4
n
4
PRO
4
A
GLY
5
n
5
GLY
5
A
CYS
6
n
6
CYS
6
A
PRO
7
n
7
PRO
7
A
SER
8
n
8
SER
8
A
SER
9
n
9
SER
9
A
TYR
10
n
10
TYR
10
A
ASP
11
n
11
ASP
11
A
GLY
12
n
12
GLY
12
A
TYR
13
n
13
TYR
13
A
CYS
14
n
14
CYS
14
A
LEU
15
n
15
LEU
15
A
ASN
16
n
16
ASN
16
A
GLY
17
n
17
GLY
17
A
GLY
18
n
18
GLY
18
A
VAL
19
n
19
VAL
19
A
CYS
20
n
20
CYS
20
A
MET
21
n
21
MET
21
A
HIS
22
n
22
HIS
22
A
ILE
23
n
23
ILE
23
A
GLU
24
n
24
GLU
24
A
SER
25
n
25
SER
25
A
LEU
26
n
26
LEU
26
A
ASP
27
n
27
ASP
27
A
SER
28
n
28
SER
28
A
TYR
29
n
29
TYR
29
A
THR
30
n
30
THR
30
A
CYS
31
n
31
CYS
31
A
ASN
32
n
32
ASN
32
A
CYS
33
n
33
CYS
33
A
VAL
34
n
34
VAL
34
A
ILE
35
n
35
ILE
35
A
GLY
36
n
36
GLY
36
A
TYR
37
n
37
TYR
37
A
SER
38
n
38
SER
38
A
GLY
39
n
39
GLY
39
A
ASP
40
n
40
ASP
40
A
ARG
41
n
41
ARG
41
A
CYS
42
n
42
CYS
42
A
GLU
43
n
43
GLU
43
A
HIS
44
n
44
HIS
44
A
ALA
45
n
45
ALA
45
A
ASP
46
n
46
ASP
46
A
LEU
47
n
47
LEU
47
A
LEU
48
n
48
LEU
48
A
ALA
49
n
49
ALA
49
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
ILE
23
A
N
ILE
23
A
O
SER
28
A
O
SER
28
1
A
A
HG
H
SER
LEU
25
26
1.03
1
A
A
HG
H
SER
TYR
28
29
1.30
3
A
A
HD11
H
LEU
LEU
47
48
1.33
4
A
A
HG
H
SER
LEU
25
26
1.10
8
A
A
O
HH21
GLY
ARG
12
41
1.53
1
A
ASP
11
77.15
65.22
1
A
ASN
16
45.49
86.28
1
A
SER
25
-63.67
-83.33
1
A
SER
38
-152.19
-32.19
1
A
CYS
42
43.93
27.72
1
A
ASP
46
-113.21
53.20
2
A
TYR
3
-169.46
-42.21
2
A
CYS
6
-55.13
170.04
2
A
ASP
11
77.77
57.97
2
A
ASN
16
44.63
85.72
2
A
SER
25
-62.03
-83.17
2
A
SER
38
-151.19
-23.20
2
A
CYS
42
46.54
28.13
2
A
ASP
46
-109.52
54.11
3
A
ASP
11
77.15
65.38
3
A
ASN
16
44.20
85.58
3
A
SER
25
-64.25
-82.39
3
A
SER
38
-148.50
-34.13
3
A
ASP
40
-38.65
119.63
3
A
CYS
42
44.84
29.21
3
A
HIS
44
-55.93
94.57
4
A
SER
2
-171.23
-26.04
4
A
TYR
3
-169.96
60.99
4
A
ASP
11
77.09
83.45
4
A
ASN
16
43.85
84.64
4
A
SER
25
-67.42
-81.75
4
A
ASP
46
-146.56
52.04
4
A
LEU
48
-147.85
-61.03
5
A
SER
2
175.37
-22.73
5
A
ASP
11
76.86
57.38
5
A
ASN
16
45.87
86.91
5
A
SER
25
-62.31
-83.11
5
A
SER
38
-139.35
-154.03
5
A
CYS
42
42.42
22.63
5
A
HIS
44
-56.56
91.95
5
A
ASP
46
-140.89
52.40
6
A
ASP
11
77.34
64.31
6
A
ASN
16
49.33
89.12
6
A
MET
21
-166.33
97.48
6
A
SER
25
-66.00
-76.42
6
A
SER
38
-143.40
-157.53
6
A
ASP
40
-58.21
108.43
6
A
HIS
44
-65.55
96.18
6
A
ASP
46
-143.03
53.09
6
A
LEU
47
-77.42
28.64
6
A
LEU
48
62.13
96.67
7
A
SER
2
-171.79
27.85
7
A
ASP
11
77.10
56.63
7
A
ASN
16
46.73
86.39
7
A
SER
25
-64.16
-83.25
7
A
ASP
46
-142.94
55.97
7
A
LEU
48
-176.50
24.33
8
A
ASP
11
77.23
81.33
8
A
ASN
16
42.63
83.64
8
A
SER
25
-66.20
-77.54
8
A
ASN
32
-106.86
79.77
8
A
SER
38
-154.19
-32.37
8
A
ASP
40
-39.54
122.73
9
A
PRO
4
-35.61
138.41
9
A
ASP
11
74.76
59.99
9
A
ASN
16
46.02
86.46
9
A
SER
25
-65.34
-81.82
9
A
SER
38
-173.80
-16.00
9
A
ASP
40
42.80
85.70
9
A
CYS
42
42.47
23.22
9
A
GLU
43
-69.99
-70.63
9
A
ASP
46
-119.86
54.25
9
A
LEU
47
-60.12
-179.54
10
A
TYR
3
-159.79
87.66
10
A
PRO
4
-49.53
-7.38
10
A
ASP
11
76.80
56.59
10
A
ASN
16
46.55
87.87
10
A
MET
21
-151.31
88.09
10
A
SER
25
-69.73
-78.65
10
A
HIS
44
-62.24
90.58
10
A
ASP
46
-142.40
54.26
MEGF/TGFALPHA44-50 CHIMERA
Solution Structure the mEGF/TGFalpha44-50 chimeric growth factor
1
N
N
A
GLY
39
A
GLY
39
HELX_P
A
GLU
43
A
GLU
43
5
1
5
disulf
2.011
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
20
A
SG
CYS
20
1_555
disulf
2.017
A
CYS
14
A
SG
CYS
14
1_555
A
CYS
31
A
SG
CYS
31
1_555
disulf
2.016
A
CYS
33
A
SG
CYS
33
1_555
A
CYS
42
A
SG
CYS
42
1_555
GROWTH FACTOR
GROWTH FACTOR, EGF GROWTH FACTOR, CHIMERIC
EGF_MOUSE
UNP
1
977
P01132
NSYPGCPSSYDGYCLNGGVCMHIESLDSYTCNCVIGYSGDRC
TGFA_HUMAN
UNP
1
83
P01135
EHADLLA
977
1018
1GK5
1
42
P01132
A
1
1
42
83
89
1GK5
43
49
P01135
A
2
43
49
2
anti-parallel
A
VAL
19
A
VAL
19
A
ILE
23
A
ILE
23
A
SER
28
A
SER
28
A
ASN
32
A
ASN
32
1
P 1